TIMOTHY MIHM: Open Payments
NPI 1659301729 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,684 in 207 payments from 20 companies in 2025. Trend: 2023 $2,463 · 2024 $3,035 · 2025 $3,684
Food & beverage: $3,664Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $634 |
| Janssen Biotech, Inc. | 28 | $570 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 57 | $559 |
| Madrigal Pharmaceuticals | 13 | $501 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $330 |
| PFIZER INC. | 11 | $196 |
| Ardelyx, Inc. | 5 | $132 |
| Regeneron Healthcare Solutions, Inc. | 3 | $106 |
| Gilead Sciences, Inc. | 5 | $100 |
| Celltrion USA Inc. | 5 | $89 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, RINVOQ, ENTYVIO, DUPIXENT, IBSRELA, LINZESS.
Industry payments across NY — which companies pay providers there.
